Physician profile
Mark Witcher
NPI 1568606747
$4,491.79
in general payments reported to CMS, 2019-2025
18 companies · $664 in 2025
The $664 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $57.56 · 2021: $244 · 2022: $712 · 2023: $1,053 · 2024: $1,297 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,012.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,493.20 | 2021-2025 | Percept PC Brainsense, Intellis Adaptivestim, Mazor X System |
| Depuy Synthes Sales INC. | $741.30 | 2020-2024 | Synthecel, Trumatch, Rapidsorb |
| Medtronic USA, INC. | $428.65 | 2019-2020 | |
| Insightec,INC | $420.22 | 2024 | Exablate |
| Boston Scientific Corporation | $276.83 | 2023-2024 | |
| Clearpoint Neuro, INC. | $243.43 | 2024 | Clearpoint |
| Stryker Corporation | $226.34 | 2022-2023 | Universal Neuro 2 |
| Integra Lifesciences Corporation | $116.75 | 2022-2023 | Cusa Clarity, Codman Hakim, Codman Certas |
| Abbott Laboratories | $100.13 | 2022 | |
| Si-Bone, INC. | $84.29 | 2022 | |
| Medical Device Business Services, INC. | $78.74 | 2024 | Synthecel |
| Sk Life Science, INC. | $72.40 | 2025 | Xcopri |
| Livanova USA, INC. | $70.17 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Neuropace, INC. | $57.29 | 2023 | |
| Baxter Healthcare | $51.09 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $20.63 | 2024 | Illuccix |
| Brainlab, INC. | $10.33 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Witcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.